We then tested the relationship between the FGFR1 or GLI2 expression level and the survival of NSCLC patients, 2437 lung cancer samples from publicly available datasets (2015 version) (http://kmplot.com/analysis/index.php?p=servicecancer=lung) were used for analysis [29]. The gene discussed is GLI2; the disease is lung cancer.